Identification of an anti-inflammatory derivative with anti-cancer potential: The impact of each of its structural components on inflammatory responses in macrophages and bladder cancer cells
- 1 May 2015
- journal article
- research article
- Published by Elsevier in European Journal of Medicinal Chemistry
- Vol. 96, 259-268
Abstract
No abstract availableKeywords
Funding Information
- Natural Sciences and Engineering Research Council of Canada (#2014-06516)
This publication has 41 references indexed in Scilit:
- Inflammatory Pathways as Promising Targets to Increase Chemotherapy Response in Bladder CancerMediators of Inflammation, 2012
- The Identification of Markers of Macrophage Differentiation in PMA-Stimulated THP-1 Cells and Monocyte-Derived MacrophagesPLOS ONE, 2010
- Emerging targeted therapies for bladder cancer: a disease waiting for a drugCancer and Metastasis Reviews, 2009
- Fluorescence‐based quantitative scratch wound healing assay demonstrating the role of MAPKAPK‐2/3 in fibroblast migrationCell Motility, 2009
- Cancer-related inflammation, the seventh hallmark of cancer: links to genetic instabilityCarcinogenesis, 2009
- Nitric Oxide Is a Key Component in Inflammation-Accelerated TumorigenesisCancer Research, 2008
- Inflammation and cancerNature, 2002
- IL-6 is an antiinflammatory cytokine required for controlling local or systemic acute inflammatory responses.Journal of Clinical Investigation, 1998
- CELLULAR RESPONSES TO INTERFERON-γAnnual Review of Immunology, 1997
- The human leukemia cell line, THP-1: A multifacetted model for the study of monocyte-macrophage differentiationCellular and Molecular Life Sciences, 1991